Safety and Efficacy of Selective Internal Radionuclide Therapy with ⁹⁰Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization

• Päätekijät: Alexander Bellendorf (Tekijä), Nicolai Mader (Tekijä), Stefan P. Mueller (Tekijä), Samer Ezziddin (Tekijä), Andreas Bockisch (Tekijä), Hong Grafe (Tekijä), Jan Best (Tekijä), Juliane Goebel (Tekijä), Thorsten D. Pöppel (Tekijä), Amir Sabet (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: MDPI AG, 2024-01-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Transarterial chemoembolization (TACE) is currently the standard of care in patients with unresectable hepatocellular carcinoma (HCC), and selective internal radionuclide therapy (SIRT) with ⁹⁰Y microspheres is mainly used as an alternative modality in patients considered poor...